您的位置: 首页 > 农业专利 > 详情页

COMPOSITION À LIBÉRATION MODIFIÉE COMPRENANT UN DÉRIVÉ DE SOMATOSTATINE EN MICROPARTICULES
专利权人:
NOVARTIS AG
发明人:
LAMBERT, Olivier,RIEMENSCHNITTER, Marc,VUČENOVIĆ, Vitomir
申请号:
MEP33109
公开号:
ME00955B
申请日:
2008.05.23
申请国别(地区):
ME
年份:
2012
代理人:
摘要:
Improved microparticles comprising a somatostatin Analogue, to a process for the preparation of these microparticles, and to pharmaceutical compositions that comprise. Kit. Use. Method of treatment.Claim 1: for an extended release Pharmaceutical composition, which comprises microparticles with a Polymer Matrix comprising one or more biodegradable Polymers and pirantel Compound as active ingredientWhere the maximum plasma concentration of the active ingredient in rabbits within the first 24 hours after the Administration of 4 mg / kg, is below 15 nanograms / milliliter.Claim 2: the pharmaceutical composition according to any one of claims 1 to 5, where the polymer Matrix comprising a Poly l u00e1ctido co glycolide linear and branched.Ovaj pronalazak odnosi se na poboljšane mikročestice koje sadrže analog somatostatina, na postupak pripreme navedenih mikročestica kao i na farmaceutske kompozicije koje sadrže isti sastojak.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充